Back to
Bank of America Corp.
NPCE
Showing 8 of 15 quarters
Position history for
Bank of America Corp.'s holdings in Neuropace, Inc.
Yes. Bank of America holds 20,249 shares of NPCE (Neuropace), worth $321,757, as of its Q2 2026 13F filing. It reduced the position by 4,449 shares (-18.0%) from Q1 2026. Bank of America has held NPCE in every 13F on record since Q4 2022, 15 quarterly filings.
Current Value
$321,757
Current Shares
20,249
Total Value Change
+$228,638
Total Shares Change
+6,889
Quarter-by-Quarter History